Danilo Moggia, Ph.D.

@danilomoggia.bsky.social

Clinical Psychologist, Psychotherapist, and Researcher Assistant Professor - Lecturer, Serra Hunter Fellow Department of Clinical and Health Psychology Autonomous University of Barcelona (UAB) @uab.cat

Has the time come to stop using "control groups" in trials of psychological interventions? — asks Pim Cuijpers. This discussion concerns psychedelic therapy, which is a (pharmacologically catalyzed) psychological intervention, just as well as any other form of psychotherapy. Link below.

Bild

. @danilomoggia.bsky.social compared outcome measures to toothbrushes (everyone their own, nobody wants to use another's). Many of measures lack #Validity, I extend: "...while not having tested whether they fit in people's mouth and clean teeth" 😜😅 #SPRKrakow2025

Jan R. Boehnke@jrboehnke.bsky.social · last yr.

Looking forward to discussing work contributing to the European Psychotherapy Consortium (EPoC)! EPoC homepage: www.psychotherapyresearch.org/page/EPoC Publication relating to these presentations: www.psycharchives.org/en/item/43cc... #SPRKrakow2025 #PsychotherapyResearch #Feedback #ROM #HRQOL

Title of a conference panel and the included talks:
Making Routine Outcome Monitoring Very Brief:
Preliminary Psychometric Properties of the EPO-1

Panel at the 56th International Annual Meeting of the Society for Psychotherapy Research
Organizer & Moderator: Danilo Moggia, University of Trier, Germany

Cross-Measure Comparisons: EPO-1 and its alignment with established measures
Emma Broglia, University of Sheffield, UK

Psychometric validation of the Polish version of the Emotional and Psychological Outcome (EPO-1)
Rafal Styla, University of Warsaw, Poland show abstract

Does One Well-Being Item Measure Something? Comparing the EPO-1 with Other Common Measures and The Existence of a Common Transdiagnostic Factor
Danilo Moggia, University of Trier, Germany

Discussant:
Jan Boehnke, University of Dundee